Press Passes Available for Experimental Biology 2012 in San Diego

FOR IMMEDIATE RELEASE

Press Passes Available for Experimental Biology 2012 in San Diego

Newswise — Bethesda, Md. (Feb. 13, 2012)—The American Physiological Society (APS) is one of six scientific societies who will hold their joint scientific sessions and annual meetings, known as Experimental Biology (EB), from April 21-25, 2012 at the San Diego Convention Center. The other participating societies are the American Association of Anatomists (AAA), American Society for Biochemistry and Molecular Biology (ASBMB), American Society for Investigative Pathology (ASIP), American Society for Nutrition (ASN) and the American Society for Pharmacology and Experimental Therapeutics (ASPET).

In past years, Experimental Biology has attracted more than 14,000 attendees, the vast majority of whom were scientists. Individual topics addressed each day are as diverse as the communication of science, drug development, adult stem cells, sustainable food systems, translational physiology, and investigative pathology.

For EB 2012, more than 2,100 abstracts have been programmed for the APS meeting. In addition to the abstract presentations there will be a variety of symposium covering topics such as:

• Hypertension and chronic kidney diseases
• Nuclear receptors in liver disease
• Novel advances in cystic fibrosis research and drug discovery
• Neurovascular mechanisms and targets in stroke, and
• Regulation of water and electrolyte balance in diabetic nephropathy.

Registration
Free registration is available to credentialed representatives of the press, and an onsite newsroom will be available. Detailed instructions for individuals who wish to request press passes are available on the website at http://bit.ly/vZ2dEh or by emailing Media@FASEB.org.

The press room will be open Saturday, April 21, through Wednesday, April 25. Pre-registration for press passes is strongly encouraged and will be accepted through April 16. A press kit with highlights of scientific research will be available on an embargoed basis prior to the meeting. Members of the media will have easy access to six society meetings in one location, more than 60 concurrent scientific sessions spanning the disciplines of the sponsoring societies, attendees from all over the world, and more than 400 company exhibit booths.

***
Physiology is the study of how molecules, cells, tissues and organs function to create health or disease. The American Physiological Society (APS; http://www.the-APS.org/press) has been an integral part of the discovery process for 125 years. To keep up with the science, follow @Phyziochick on Twitter.


The rest is here:
Press Passes Available for Experimental Biology 2012 in San Diego

DNA Results Are In: Canned Sardines Are Kosher

Just so you know: Canned sardines are kosher.

This judgment would appear to be definitive, based on DNA evidence. Genetic testing by a parasitologist at the American Museum of Natural History has confirmed that the recent discovery of small worms in canned sardines does not render them treyf, or unkosher. It may render them unappetizing, but that judgment is up to the consumer (more on that later).

The museum got involved last March when rabbis from the Orthodox Union, which certifies as kosher hundreds of thousands of products across the world, sought scientific help in resolving a question that arose when they began finding the worms, or nematodes, in cans of sardines.

Talmudic debates can turn on fine distinctions, but this was relatively straightforward. The presence of worms could have been a sign that, during the preparation of the canned sardines, muscle from the fish had been improperly handled and allowed to mix with intestinal contents of the sardines, rendering them unkosher.

The issue was important because it “could have led to sardines losing certification as kosher,” said Dr. Mark Siddall, a curator and professor in the invertebrate department of the museum, who conducted the testing. Many consumers, including non-Jews, look for the certification label as a sign of quality assurance in food preparation.

The rabbis brought their samples of sardina pilchardus — the Mediterranean sardine — to the museum, where Dr. Siddall conducted so-called “DNA bar-coding” to analyze the species of the worms. Their DNA was isolated and two variants of the cytochrome oxidase gene — which is different for every animal species, as unique as a fingerprint, Dr. Siddall said — revealed that the type of worms in the samples reside only in the flesh of sardines. “This meant that there was no evidence that the intestines and the flesh had been commingled,” Dr. Siddall said.

The Orthodox Union also discovered evidence of worms in cans of orange capelin roe, and Dr. Siddall’s testing confirmed that the worms, as well, were not intestine-dwellers. The analysis of Dr. Siddall and his colleagues has been published in The Journal of Parasitology, and the union has formally ruled that both the sardines, and the capelin roe, are kosher. (The entire paper can be read below.)

In 2004, a similar Talmudic tempest involved a tiny crustacean known as a copepod, which was discovered swimming in New York City’s tap water, spurring debate among the observant about whether it rendered city water unkosher. Many contended that the crustacean was a distant relative of shrimp and lobster, shellfish that cannot be consumed because they lack fins and scales. The Orthodox Union recommended that city water be filtered before using it for drinking and cooking. That prompted restaurants to install filters, some costing more than $1,000, to remove the interlopers.

As for worms in sardines or in any fish, Article 81 of the New York City Department of Health Code has long required that “aquatic animals, fish or molluscan shellfish” be cooked, rendering such parasites harmless — unless customers assume some risk by asking for raw fish, as in sushi. The best sushi masters constantly examine the fish for evidence of parasites.

“The notion that there are worms in fish flesh is not new,” Dr. Siddall said. “As long as they’re cooked, or frozen first, they’re perfectly safe.”

Yes, but if the sardines are both safe and kosher, are the worms themselves — which are barely visible and look like thin whitish threads — disgusting?
“It is up to the individual’s aesthetic as to whether that is ‘yucky,’ ” Dr. Siddall said. “I’ve eaten worse. Curdled goose blood. Rhino beetle larvae. Both yummy. But that’s another story.”

Journal of Parasitology paper

Read more:
DNA Results Are In: Canned Sardines Are Kosher

Posted in DNA

American Council on Exercise Adds Three Senior Fitness Consultants

SAN DIEGO, Feb. 13, 2012 /PRNewswire/ -- Fitness industry experts Natalie Digate Muth, MD, MPH, RD; Michael R. Mantell, Ph.D., and Chris McGrath, MS, CPT, LWMC, join the team of fitness experts at the American Council on Exercise (ACE), America's leading authority on fitness and the world's largest nonprofit fitness and personal trainer certification, continuing education and training organization.  The addition of Mantell, Muth and McGrath as senior consultants to ACE is part of the organization's ongoing efforts to inspire, motivate and encourage people to make physical activity an integral part of their everyday lives with an end goal of reversing the obesity epidemic affecting millions of Americans.

"At ACE, we are collaborating with the top experts in the industry to improve fitness literacy for professionals and fitness seekers alike," said ACE CEO Scott Goudeseune.  "Muth, Mantell and McGrath bring more than 50 years of combined industry experience and a wealth of knowledge on topics from nutrition and wellness to training and injury prevention, and everything in between." 

Muth joins ACE as a Senior Fitness Consultant focusing on nutrition and weight management.  She will contribute to ACE's vast continuing education and certification programs, and provide nutrition and weight management content for ACE's educational materials. An ACE-certified Personal Trainer and Group Fitness Instructor, Muth is a pediatrics resident at UCLA Mattel Children's Hospital, a registered dietitian and Board-Certified Specialist in Sports Dietetics (CSSD).

Mantell, an internationally recognized thought leader in the fitness industry, joins ACE as Senior Fitness Consultant on Behavioral Sciences. In this position, he'll provide counsel on the latest findings in health behavioral psychology to optimize overall wellbeing.  Since earning his doctorate at the University of Pennsylvania, Mantell has coached world-class athletes and fitness enthusiasts for performance enhancement and consults with major fitness companies and organizations throughout the country.  He is a two-time best-selling author appearing regularly on radio and television.

McGrath, founder and operator of Movement First, a New York City-based fitness education, consulting, and training organization, brings more than 20 years of fitness experience to ACE in his position as Senior Fitness Consultant. He specializes in a variety of training and coaching modalities, including sports performance, injury prevention, post-rehabilitation and lifestyle/wellness coaching. McGrath will assist ACE in the education of personal trainers, group fitness instructors, and other fitness professionals on the proper movement patterns for safe and effective training so that they may pass this knowledge on to their clients.  He is an international lecturer, educator, and consultant for some of the most successful fitness organizations in the world including Functional Movement Systems, TRX, Reebok, Star Trac, EA Sports Active and numerous others.  He holds a Master of Science in exercise science from California University in Pennsylvania, a Bachelor of Science in health education from Western Connecticut State University and has numerous training and coaching certifications.

"As the fitness continuum continues to evolve to include overall health and wellness, ACE is also expanding with new thought leadership to help meet the growing needs for enhanced professional education as well as greater public education and access to fitness services," said American Council on Exercise's Chief Science Officer, Cedric X. Bryant, Ph.D.  "The depth and diversity of experience that all our fitness experts possess is a powerful asset in helping us have a meaningful impact on the physical activity, nutrition, and lifestyle habits of Americans."

For more information on the various educational resources that ACE provides to more than 50,000 dedicated fitness professionals, visit http://www.acefitness.org/getcertified.    

About ACE
The American Council on Exercise (ACE), America's premier fitness and personal trainer certification, continuing education, and training organization, is a nonprofit organization dedicated to promoting the benefits of physical activity and protecting Americans against unsafe and ineffective fitness products and instruction.  ACE sponsors university-based fitness and exercise science research studies and is the world's largest nonprofit fitness certifying organization.  For more information on ACE and its programs, call (800) 825-3636 or visit the ACE website at http://www.acefitness.org.  AMERICAN COUNCIL ON EXERCISE, ACE and the ACE logos are Registered Trademarks of the American Council on Exercise.

See the rest here:
American Council on Exercise Adds Three Senior Fitness Consultants

Plastic surgery reported up in sagging economy

Anti-aging procedures that don’t involve going under the knife drove the growth of cosmetic medicine in 2011, a new report from the American Society of Plastic Surgeons says.
.
The plastic surgery market saw  ”signicant” growth for the second year in a row, the group says, with cosmetic and reconstructive plastic surgery each up 5%.

“While the rate of economic recovery in the U.S. is still uncertain, 2011 proved to be a good year for plastic surgery,” ASPS President Dr. Malcolm Z. Roth said.

Some local plastic surgeons in Orange County, one of the cosmetic medicine capitals, see things somewhat differently. 

“Even though these statistics are derived from surveying our membership, I find them not totally credible,” said Dr. Edward Jonas Domanskis of Newport Beach. “In my experience, the total number of cosmetic surgery procedures, both surgical and non-surgical, has either decreased from the past year or stayed the same.”

Dr. John Di Saia of San Clemente and Orange took the report in stride.

“Things are looking up in the cosmetic surgery market but only slightly. 5% is not a major increase,” he said. “The larger procedures are still slow to return in large numbers. It is a sign of the economy.”

Another plastic surgeon said he thinks the statistics are spot on.

“The recent figures from the American Society of Plastic Surgeons on procedures performed in 2011 are consistent with the trends in my practice,” said Dr. Donald Altman of Irvine, adding, “… Despite the modest increase in procedures performed in 2011, consumers seeking cosmetic surgery continue to be very price sensitive.”

 The ASPS says 13.8 million cosmetic plastic surgery procedures — both surgical and minimally-invasive such as Botox or filler injections – were performed in the United States in 2011.

Also, 5.5 million reconstructive plastic surgery procedures were performed last year, up 5%, as well.

Cosmetic surgery went up 2%, with nearly 1.6 million procedures in 2011, the ASPS said.

The top five surgical procedures were:

Breast augmentation (307,000 procedures, up 4%) Nose reshaping (244,000 procedures, down 3%) Liposuction (205,000 procedures, up 1%) Eyelid surgery (196,000 procedures, down 6%) Facelift (119,000 procedures, up 5%)

Facelifts were listed among the top five cosmetic surgical procedures for the first time since 2004, replacing tummy tucks.

“We are seeing notable increases in surgical procedures, such as facelifts, that reflect the demands of an aging boomer population,” Roth said. ”However, the overall growth in cosmetic procedures is being primarily driven by a substantial rise in minimally-invasive procedures.”

Cosmetic minimally-invasive procedures increased 6%, with nearly 12.2 million procedures in 2011, according to the ASPS.

The top five minimally-invasive procedures were:

Botulinum toxin type A — mostly Botox (5.7 million procedures, up 5%) Soft tissue fillers (1.9 million procedures, up 7%) Chemical peel (1.1 million procedures, down 3%) Laser hair removal (1.1 million procedures, up 15%) Microdermabrasion (900,000 procedures, up 9%)

Soft tissue fillers like hyaluronic acid (such as Restylane and Juvederm Ultra), calcium hydroxylapatite (Radiesse), and fat injections had  some of the largest growth in the minimally-invasive market last year.

The ASPS said more than 1.3 million hylauronic acid procedures were performed in 2011, up 9%; 286,000 calcium hydroxylapatite procedures, up 36%; and 68,000 fat injections, up 19%.

Lip augmentation practically exploded – up 49%, with more than 25,000 procedures performed, according to the ASPS.

Procedures by gender will be released in upcoming weeks. But chin augmentation, a procedure the ASPS says is popular with men, nearly doubled in 2011, with 21,000 procedures performed, up 71%, according to the organization. 

Here’s some more from local plastic surgeons:

Dr. Terry Dubrow of Newport Beach:

“I think these numbers reflect that things have pretty much stabilized. No great increases or decreases in the demand or utilization of plastic surgery. The fact that most procedures seem to be up in single digit percentage point gains reflect in my mind nothing more than statistical variation. I have a rather established practice and I appear frequently on television and despite that some months last year were slower than I would expect if things were really improving.”

Dr. Edward Jonas Domanskis of Newport Beach:

“Definitely, the surgical cosmetic procedures continue at least in my practice and Orange County, to be significantly impacted by the economy with less expendable and spendable income. I feel that this is also because consumers confidence levels are still low.”

Dr. Donald Altman of Irvine:

“Breast augmentation continues to be the most popular cosmetic surgical procedure followed by rhinoplasty. There has been a dramatic increase in breast reconstruction this past year. Patients seem to be better informed in their decisions regarding cosmetic surgery, probably reflecting their increased ability to access information online. Email and text messaging has improved my ability to communicate with patients exponentially.”

.

See also:
.

 

 ————————————————————————————————————————————————–

.

Latest from this blog:
.

.

More here:
Plastic surgery reported up in sagging economy

The Gamida Cell-Teva Joint Venture Concludes Enrollment for the Phase III Study of StemEx®, a Cord Blood Stem Cell …

JERUSALEM--(BUSINESS WIRE)--

Gamida Cell announced today that the Gamida Cell-Teva Joint Venture (JV), equally held by Gamida Cell and Teva Pharmaceutical Industries, has enrolled the last of 100 patients in the international, multi-center, pivotal registration, Phase III clinical trial of StemEx, a cell therapy product in development as an alternative therapeutic treatment for adolescents and adults, with blood cancers such as leukemia and lymphoma, who cannot find a family related, matched bone marrow donor.

StemEx is a graft of an expanded population of stem/progenitor cells, derived from part of a single unit of umbilical cord blood and transplanted by IV administration along with the remaining, non-manipulated cells from the same unit.

Dr. Yael Margolin, president and chief executive officer of Gamida Cell, said, "The JV is planning to announce the safety and efficacy results of the Phase III StemEx trial in 2012 and to launch the product into the market in 2013. It is our hope that StemEx will provide the answer for the thousands of leukemia and lymphoma patients unable to find a matched, related bone marrow donor.”

Dr. Margolin continued, “StemEx may be the first allogeneic cell therapy to be brought to market. This is a source of pride for Gamida Cell, as it further confirms the company’s leadership as a pioneer in cell therapy. In addition to StemEx, Gamida Cell is developing a diverse pipeline of products for the treatment of cancer, hematological diseases such as sickle cell disease and thalassemia, as well as autoimmune and metabolic diseases and conditions helped by regenerative medicine.”

About Gamida Cell

Gamida Cell is a world leader in stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. The company’s pipeline of stem cell therapy products are in development to treat a wide range of conditions including blood cancers such as leukemia and lymphoma, solid tumors, non-malignant hematological diseases such as hemoglobinopathies, acute radiation syndrome, autoimmune diseases and metabolic diseases as well as conditions that can be helped by regenerative medicine. Gamida Cell’s therapeutic candidates contain populations of adult stem cells, selected from non-controversial sources such as umbilical cord blood, which are expanded in culture. Gamida Cell was successful in translating these proprietary expansion technologies into robust and validated manufacturing processes under GMP. Gamida Cell’s current shareholders include: Elbit Imaging, Clal Biotechnology Industries, Israel Healthcare Venture, Teva Pharmaceutical Industries, Amgen, Denali Ventures and Auriga Ventures. For more information, please visit: http://www.gamida-cell.com.

See the original post:
The Gamida Cell-Teva Joint Venture Concludes Enrollment for the Phase III Study of StemEx®, a Cord Blood Stem Cell ...

Group slams Arizona science standards

by Kerry Fehr-Snyder - Feb. 12, 2012 09:38 PM
The Republic | azcentral.com

High-school standards covering chemistry and physiology are "distressingly inadequate.''

Evolution gets short shrift.

And guidelines to help students grasp modern biology are "skimpy.''

For those and other reasons, Arizona has earned a "D" for its school science standards from the non-profit Thomas B. Fordham Institute, based in Washington, D.C., and Dayton, Ohio.

"Arizona's science standards are generally weak on content and are plagued by disorganization and a frustrating lack of cohesion,'' the institute reported in January. The group describes itself as committed to the renewal and reform of primary and secondary education in the United States.

Other states received even harsher criticism. Ten received an "F" for their standards, including Wyoming, Wisconsin and Montana. Only California and the District of Columbia received an "A."

The grades were based on an examination of the current K-12 science standards for every state and District of Columbia.

In issuing the report, the institute said high science standards are necessary if America is to remain "prosperous, scientifically-advanced and economically competitive.''

Arizona is among several states beginning to establish a common set of science standards that will be internationally benchmarked. The framework is known as the next-generation science standards.

"One of the issues has been and will be that states set their own standards," said Darcy Renfro, vice president and director of science, technology, engineering and math initiatives at Science Foundation Arizona. "There is a great mismatch of science standards."

Unlike math and English, there is no common core standard for science adopted by all states.

Arizona's grade on science standards mirrors those given in 2005 when the last review of national science standards was conducted. The study comes as businesses and schools are trying to boost education in STEM to compete in the global economy and for national security.

"It's incredibly important to American competitiveness and our national security," said Kathleen Porter-Magee, senior director of high-quality standards for the institute.

Researchers criticized Arizona for "spotty and unsystematic" science standards in high school.

They also faulted Arizona for:

Employing disorganized standards.

Poorly conceiving concepts under which standards are grouped.

Read more:
Group slams Arizona science standards

Innovative Imaging Concepts is Excited to Announce the Distribution of Collibio, the Next Generation of Digital …

Pathology departments are very familiar with the age old problems of dealing with the costs and inflexibilities of trying to manage large archives of glass slides. In addition trying to collaborate with colleagues in different locations using glass slides is a major challenge. Slide trays have to be sent to/from laboratories in different locations incurring significant costs, tying up logistical manpower, causing ongoing delays in diagnoses, and with the danger of slides

getting lost or damaged. Alternatively pathologists have to travel to meet their colleagues for team meetings, to review important cases, thereby incurring additional costs and the loss of important work days. Collibio is solving these problems.

Oxford, Massachusetts (PRWEB) February 13, 2012

The Ireland based pathology imaging software company Pixcelldata announces the availability of Collibio in USA with the authorized distributor Innovative Imaging Concepts.

Collibio helps the users of proprietary digital scanner systems and their images now to collaborate immediately.

Collibio’s ease of use allows pathologists to quickly connect to existing virtual slide repositories. New scans are automatically linked into Collibio and in conjunction with a LIS relevant case information is displayed alongside slides. Virtual slides can be shared with other lab users and also securely with consultants outside of the pathologist’s organization providng rapid turnaround time for external review. Conferences can be initiated between any number of collaborators allowing simultaneous review of slides between colleagues. Collibio will reduce the administration overhead of a digital pathology laboratory, and allow pathologist to access their slides regardless of where they or their slides are.

Pixcelldata released Collibio as a web application in October 2010 and expanded their software offering by creating a desktop version. The Collibio desktop application provides a multi-monitor “pathologist’s cockpit,” allowing users to increase their productivity and effectively manage their digital pathology projects.

“We were keen to provide our clients with the tools they need to enhance their user experience and efficiently manage large quantities of data generated through using digital slides,” explained Alex Johnson, Pixcelldata's CTO. “One screen can be used to view images, and another to display auxiliary information. The application installs in seconds on Windows, Linux, and Mac OS X, and all data is immediately saved on a central server.”

Alan Hanley, Pixcelldata’s CEO commented, “We want to help our clients maximize the use of their time and resources. The Collibio desktop application is the perfect tool to use while at your office workstation and the rich internet application software provides immediate access to your data with the same functionality when on the move. We will continue to focus on new product development throughout 2011 and will release an innovative tablet PC version of Collibio later this year.”

Company Profile

Innovative Imaging Concepts

340 Main Street

Oxford, MA 01540

Phone 508 581 0251

Fax 508 987 7310

The company includes interactive digital slide imaging system and several emerging product innovations created and commercialized for advanced pathology digital microscopy imaging in the fields of tissue analysis, ophthalmology diagnosis and surgery, skin cancer detection and general optical microscopy imaging. The corporate mission is to position Innovative Imaging Concepts as a new product development company, generating imaging hardware applications and the imaging software technology for integrating medical imaging, storage, retrieval, and sharing of hospital, clinical pathology, research and patient diagnostic imaging between local medical services and research departments and through internet connection to a broader and concurrent viewing audience.

Company Profile

Pixcelldata Ltd.

51/52, Fitzwilliam Square,

Dublin 2,

Ireland.

T +353 (1) 6650449

F +353 (1) 6650480

Pixcelldata is a software company committed to providing innovative software solutions for the digital pathology domain.

Our products are built with perfection, usability and enterprise level features in mind.

We work hard to understand how our customers operate and deliver applications that fit seamlessly into their every day workflows. __title__ Collibio, innovative software solutions for the digital pathology domain]

###

Ludwig Eckl
ludwig.eckl@gmail.com
413 262 5940
Email Information

Excerpt from:
Innovative Imaging Concepts is Excited to Announce the Distribution of Collibio, the Next Generation of Digital ...

Nutrition Study: Matthew Vettese Says Afternoon Stress Eating is Dietary Disaster, Suggests Healthy Alternatives

A new report from CNN confirms that stress-induced “binge eating” during the afternoon or early evening is a major cause of dietary problems and significant weight gain, but nutritionist Matthew Vettese offers ways for avoiding carbohydrate overload.

New York, New York (PRWEB) February 13, 2012

Eating the wrong kinds of foods and later feeling sick because of it is an experience most of us know well, but a new CNN study suggests that the opposite can also hold true—that certain foods can make us feel better, at least temporarily. The nutrition study notes that junk foods, such as potato chips and ice cream, offer a “fast-track to happiness,” but also that a “carb overload” can ultimately “wreak havoc” on the body. CNN speculates that afternoon snacking and easy access to junk food are the causes of many dietary and weight gain problems, but nutrition expert Matthew Vettese says there are practical efforts that can be taken to ward off the problem.

Matthew Vettese confirms that the CNN study offers important insight that many consumers may benefit from hearing. “It is certainly true that eating certain foods can have a soothing or comforting effect, which is why so many of us reach for chips or for that extra cup of coffee in the afternoon,” says the diet expert. “Just because something makes one feel good does not mean it is actually good for the body, however, and the things we do to feel better may really be making us feel worse.”

Nutrition expert Matthew Vettese points to the CNN study’s insight into what makes afternoon snacking and stress-induced “binge eating” so counterproductive. In particular, the study shows that overloading on unhealthy foods can actually suppress the immune system, a finding Matthew Vettese says is radical. “A lot of times we flood our bodies with junk when we start to feel ill, but that can actually make things much worse,” he cautions.

The best path to avoiding these unhealthy dietary effects, according to Matthew Vettese, is to recognize the problem and end the pattern. “These foods not only taste good, but prove to be addictive over time,” he comments. “Once we start eating donuts or potato chips as an afternoon snack, our bodies start to crave them, and it becomes hard to end the cycle, even though it makes the body feel worse and worse.”

The nutritionist endorses a suggestion from the CNN report, which is to substitute a different kind of stress-relieving afternoon habit. Rather than relieve midday stress or cope from a hard day by binge eating, Matthew Vettese recommends making it a habit to go for a short walk, a healthier alternative that has the same stress-reducing effects. He also adds another suggestion of his own, which is simply to take junk out of the equation. “If you know you are prone to afternoon snacking, keep less carb-heavy snacks, like fruits or veggies, close at hand, and avoid the allure of the sweet and salty stuff.”

ABOUT:

Matthew Vettese is a nutrition expert and dietary consultant whose passion is for helping his client find safe and natural ways to lose weight and stay trim. He is also a strong proponent of organic gardening, and offers his clients home gardening tips.

###

Michael McGarety
PR Authority
800-475-2390
Email Information

Read the rest here:
Nutrition Study: Matthew Vettese Says Afternoon Stress Eating is Dietary Disaster, Suggests Healthy Alternatives

Metagenics’ Chief Science Officer, Dr. Jeffrey Bland, Is Awarded Nutrition Business Journal’s 2011 Education Award

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--

Jeffrey Bland, PhD, chief science officer for Metagenics, Inc., a nutrigenomics and lifestyle medicine company dedicated to reducing chronic illness and improving health, has been awarded the 2011 Nutrition Business Journal’s (NBJ) Education award for his expertise and contributions to international nutritional medicine education. The NBJ awards give recognition to the industry’s influential leaders who have made a significant impact in the fields of health, wellness and nutrition.

“I am honored to receive the Nutrition Business Journal’s Education award,” said Dr. Bland. “Educating healthcare practitioners in the science of nutrigenomics is the key to reversing the tide of chronic illness that is currently overwhelming our healthcare system worldwide. As more and more practitioners and patients discover the power of lifestyle medicine to achieve life-long health, we are at the tipping point of shifting our focus from treating disease to creating health.”

For more than 25 years, Dr. Bland has been an internationally recognized leader in the nutritional medicine field. A nutritional biochemist, he is a prominent researcher and educator for the science of nutrigenomics, the study of how nutritive substances and phytochemicals affect genetic expression within human cells.

Dr. Bland currently serves as the chief science officer for Metagenics and is the president of Metagenics’ wholly-owned subsidiary, MetaProteomics Nutrigenomics Research Center. His scientific team has published more than 80 peer-reviewed articles and been awarded more than 50 international or domestic patents. Their research is the foundation for Metagenics’ industry-leading products and programs that reduce chronic illness and improve health.

In addition to lecturing and teaching on nutrigenomics around the world, Dr. Bland leads and shapes hundreds of educational programs offered through Metagenics University, including the certification programs for First Line Therapy (FLT), a personalized lifestyle program centered on therapeutic lifestyle change.

Dr. Bland’s leadership in nutrigenomics education also includes achievements such as:

Professor of biochemistry at the University of Puget Sound. Director of nutritional research at the Linus Pauling Institute of Science and Medicine. First member of the board of trustees of Bastyr University, the first federally accredited university in the United States offering graduate and undergraduate degrees in natural medicine. Dr. Bland contributed significantly to its founding and accreditation. Establishment of the Institute of Functional Medicine to educate clinicians about functional medicine. President at the Northwest Academy of Preventive Medicine Author of the textbook, The Medical Applications of Clinical Nutrition, that has been used in numerous medical and graduate school curriculums

Dr. Bland will be publicly honored for his outstanding achievements in nutrition medicine education at the 15th annual NBJ Summit in Dana Point, California, on July 24-27.

About Metagenics, Inc.

Metagenics, Inc. (www.metagenics.com) is a nutrigenomics and lifestyle medicine company focused on reversing chronic illness and improving health. Founded in 1983, Metagenics serves more than 75,000 healthcare providers worldwide through premium quality, science-based medical foods, nutritional formulas, and lifestyle therapy programs to help their patients achieve a lifetime of good health. Metagenics’ scientific staff—among the largest in the nutrigenomics industry—has published more than 80 articles in peer-reviewed journals and has been awarded more than 50 international or domestic patents. The company’s educational arm, Metagenics University, collaborates with renowned medical experts to annually deliver more than 200 events designed to help healthcare professionals stay on the leading edge of lifestyle medicine and incorporate nutrition into their clinical practice.

Metagenics maintains its corporate headquarters in San Clemente, CA; R&D headquarters in Gig Harbor, WA; and operating subsidiaries in Brussels, Belgium, and Brisbane, Australia.

Originally posted here:
Metagenics’ Chief Science Officer, Dr. Jeffrey Bland, Is Awarded Nutrition Business Journal’s 2011 Education Award

BD Acquires KIESTRA Lab Automation BV

More Topics: Choose a Sector Accounting Firms Advertising/Media/Communications Capital CEO/Board General Business Health/Biotech Internet/Technology Investment Firms Law Firms Mergers & Acquisitions Money Managers People Private Companies Public Companies Venture Capital

Posted February 13, 2012

Provides Automation Platform to Offer Integrated Microbiology Lab Solutions

FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired KIESTRA Lab Automation BV, a Netherlands-based company that designs, develops, manufactures, markets and sells innovative lab automation solutions for the microbiology lab. The financial terms of the acquisition were not disclosed. The transaction is expected to be slightly dilutive; however, BD reaffirms its previous guidance that reported diluted earnings per share from continuing operations for fiscal year 2012 are expected to be in the range of $5.60 to $5.70.

For further information, read more on BD's website.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit http://www.bd.com.

To find out more about the company in this article and to see if you
have business connections, click below:

Please enable JavaScript to view the comments powered by Disqus. blog comments powered by

Continue reading here:
BD Acquires KIESTRA Lab Automation BV

The Longevity Opportunity in the U.S. is Comparable to Emerging BRIC Markets

America’s Leading Analysts Reveal the Opportunities for Investment and Business Growth in Serving Baby Boomer Consumers at What’s Next Boomer Business Summit in Washington, D.C.

Lafayette, California (PRWEB) February 13, 2012

In 2011 the first of the baby boomer generation began turning 65 years old. Near daily stories in the media are generated about the issues, needs, impact, influence and sheer size of the eldest of our population. The growing discourse includes changes to retirement trends, the fact that the 55+ age group is the fastest-growing segment of entrepreneurs, the call to advertisers that they can no longer afford to ignore this audience, and announcements of new outlets catering to these demographics. From aging-in-place technologies to social and mobile media, to the spending power of grandparents, the overall wealth of opportunities in meeting the needs of this mature market is the purpose of the ninth annual What's Next Boomer Business Summit, being held March 28 in Washington, D.C. There the country’s leading analysts, top researchers and executive strategists will gather to introduce new research, products and services, and to present the definitive ways to reach and successfully sell to baby boomers and senior consumers. It is the event to meet the entrepreneurs and brand teams pursuing the baby boomer customer, and learn the marketing strategies that work to reach them.

It opens with a keynote delivered by veteran political strategist Donna Brazile, on ‘Designing a Personalized Business Model for the New Economy’. Jody Holtzman, SVP of Thought Leadership Group at AARP will define and examine the entrepreneurial and market opportunities related to the new Longevity Economy. His keynote will unearth current economic activity related to the demographic phenomenon of people living longer, richer lives and will address areas where the needs and wants of Americans 45 and older are not being met. Also, he will present a new framework for approaching both the societal needs and economic opportunities related to a changing and vital population.

The event tracks will explore trends in the following areas, with agenda highlights:

Often cited as worth the cost of registration alone, the ‘Lunch with the Experts’ is every attendee’s chance for exclusive access to the best analysts, authors, bloggers, and boomer market experts at this summit. The list of table hosts is available at http://boomersummit.com/lunch.html.

The complete list of speakers is available at http://www.boomersummit.com/speakers.html.

"The boomer, senior and caregiver markets are large and growing. The changing economy has created a shift in spending that is becoming the new normal. This conference brings together the most innovative companies and top thought leaders in marketing, innovation and distribution,” Mary Furlong, What’s Next conference producer shared. “These markets are growing as rapidly as the emerging markets of Brazil, Russia, India and China. Join us in March to discover the important segments in the longevity economy."

A press conference will take place on March 29 at 11:00 a.m. at the National Press Club. Speakers and sponsors will be making their new research product and service announcements.

Sponsors of What’s Next Boomer Business Summit are, at the platinum level: AARP, UnitedHealthcare and Crew Media; at the gold level: Microsoft, Linkage, Silverado Senior Living, MBO Partners, RLTV and Caring.com; at the silver level: General Mills, Google, GreatCall, Facetime Strategy, The Hartford, SilverRide, GrandCare Systems, Innovate LTC, Independa Inc., Starkey; at the bronze level: ABHOW, Hipcricket, Posit Science, MetLife Mature Market Institute, VibrantNation; refreshment break sponsor is Moving Mavens and Moving Solutions.

Registration, agenda and additional event details available at http://www.boomersummit.com. Registration costs are $275 at early bird rate (extended to February 21), $350 at the advance rate (February 22 to March 26) and $450 on March 27 and onsite.

What’s Next Boomer Business Summit

The ninth Annual What’s Next Boomer Business Summit is produced by Mary Furlong & Associates. What’s Next Boomer Business Summit is affiliated with the American Society on Aging (ASA) Aging in America Conference being held on March 28 to April 1, 2012 in Washington, D.C. Registration and program information is available at http://www.boomersummit.com. Facebook page is http://www.facebook.com/pages/2012-Whats-Next-Boomer-Business-Summit. Twitter username is WhatsNextBoomer, and hashtag is #boomersummit. It is produced by Mary Furlong & Associates.

Mary Furlong & Associates

Founded in 2003, Mary Furlong & Associates (MFA) works with companies seeking to capitalize on new business and investment opportunities in the Baby Boomer market. MFA provides business development, financing strategy and integrated marketing solutions to entrepreneurs, corporations and non-profit organizations serving the 50+ market. Mary Furlong, Ed.D., the firm's founder and CEO, has guided the offline and online 40+ market strategies of leading corporations and non-profit organizations for more than 20 years. In 2011, Furlong was honored as one of the top 100 Women of Influence by the Silicon Valley Business Journal. Furlong is Dean's Executive Professor of Entrepreneurship at Santa Clara University's Leavey School of Business, and previously founded SeniorNet and ThirdAge Media. Her latest book, Turning Silver into Gold: How to Profit in the New Boomer Marketplace (FT Press), was published in 2007. More information available at http://www.maryfurlong.com.

###

Michelle Bauer
Mary Furlong & Associates
727-510-2524
Email Information

Original post:
The Longevity Opportunity in the U.S. is Comparable to Emerging BRIC Markets

Twin brothers’ devastation after both rapidly lost their sight due to rare genetic condition

By Julian Gavaghan

Last updated at 11:00 AM on 13th February 2012

Twin brothers have told of their ‘devastation’ after both dramatically lost their sight to a rare condition that affects just a few hundred people.

Michael and Dan Smith, 20, are still determined to finish university and get good jobs after being left almost totally blind by Leber's Optic Neuropathy.

Michael, who is in football training for this year's Paralympic Games, lost his sight in a matter of weeks while in his first year at Bart's and the London School of Medicine.

Rare condition: Dan (left) and Michael Smith suffer from Leber's optic Neuropathy

Less than a year later, his brother Dan suffered the same fate while in his second year studying aeronautical engineering at the University of Bristol.

The identical pair, who can only make out shadowy shapes, have been forced to adapt their lives, learning Braille and re-learning how to cook and choose clothes.

 

They also plan to embark on a 350-mile tandem bike ride from London to Amsterdam in April.

Michael first noted changes to his vision in November 2009, forcing him into the ‘crushing’ realisation he could not continue his degree in medicine.

WHAT EXACTLY IS LEBER'S OPTIC NEUROPATHY?

Leber's Optic Neuropathy is a hereditary condition passed on by the mother’s genes.

The genetic defect, which can lead to optic nerve damage – or neuropathy, is carried by roughly one in every 9,000 people.

But genes, which can cause eye cells to die off quickly, can pass though several generations without triggering the condition.

Around 50 per cent of men and 80 per cent of women with it will suffer no loss of vision. No reason is known for the difference between the sexes.

In the Smith brothers’ case, they have been unable to find any family history of sudden onset blindness going back four generations.

The main symptom is the sudden loss of vision, which is caused by a death of cells in the optic nerve responsible for relaying visual information from the eyes to the brain.

Once cells start dying, affected eyes will begin seeing colours that appear more washed out. Within a period of eight weeks, it can lead to near or total blindness.

In many cases, only one eye is affected and patients may not be aware of the loss of colour vision until the doctor asks them to cover the healthy eye.

Most of the time, however, both eyes are affected. Sometimes vision improves, although this is very unusual.

‘My symptoms came on suddenly - one day I was in a lecture and I could not make out the projector in front of me, it was really hazy,’ he said.

‘I lost 70 per cent to 80 per cent of vision in my left eye in a very short space of time.

'I continued at medical school for a couple of weeks but it was taking me half an hour to read a page of A4 and I was breaking down in tears.

‘I did not know what was happening to me. I could not recognise people's faces and I quickly lost my independence.’

A genetic test eventually revealed Michael was suffering from the rare genetic condition, which also caused rapid sight loss in his right eye.

‘It was the end of life as I knew it,’ he said. ‘I could not carry on at medical school and that was incredibly distressing. In fact, it was crushing.

‘I can never describe how devastating it was to give up on medicine.

‘Not only that but I couldn't go for a run on my own without it being dangerous, I could not prepare food, I did not know what I was wearing.’

Dan also ‘could not comprehend what was happening’ when he heard Michael's news.

‘Michael has been the closest person to me all my life and this struck him in his first week at university,’ he said. ‘It was incredibly hard to see this happening to my brother.

‘He called me to say he thought something was wrong - he wasn't able to recognise people but didn't know why. That conversation still haunts me.

‘Doctors initially thought he had a brain tumour but tests revealed that he had this rare genetic disorder.

‘The whole family was devastated as we tried to comprehend what had happened.

‘It was the cruellest of timing because it was my brother's first term at medical school and he had his whole life ahead of him.’

But further terrible news was still to come. Because the pair are identical twins, Dan was told he had a 60 per cent to 70 per cent chance of also going blind.

Optic neuropathy: Cracks show nerve damage in the eye, caused by cells dying

‘Knowing I could lose my sight was psychologically very, very tough,’ he said.

‘Leber's Optic Neuropathy is known as 'The Sword of Damocles', based on the Greek parable, because your life goes from being great, in a period of heightened happiness, to hitting rock bottom in an instance.

‘I had a pretty tough time knowing that this dark cloud was hanging over me during my first two years at university.

‘It was effectively like sitting on a time bomb that could have gone off at any moment.’

In Easter 2010, Dan began to lose sight in his left eye and within three weeks there was also ‘full scale deterioration’ in his right eye.

Michael said: ‘Once I was diagnosed, the one thing I wanted in life was for this not to happen to my brother too.’

Although Leber's Optic Neuropathy is a hereditary condition, the brothers have been unable to find any family history going back four generations.

The twins, from Barnet, north London, can now make out shadows but use white canes to help them move around.

It is not known if they will lose their remaining sight but their condition is extremely unlikely to improve.

Nevertheless, they are determined to live life to the full. Michael is now studying geography at King's College London and wants to be a disability lawyer when he graduates.

Dan is still studying aeronautical engineering and aims to go into investment banking.

Michael said: ‘The last two years have been the most difficult but also the most exciting of my life.

‘We have had to learn new skills such as Braille and a new computer language that coverts text to speech. In lectures, we have note-takers.

‘Everything is through touch now, I select clothes through touch and texture and cooking is through touch and smell.

‘I thought I would never smile again, but we wanted our lives back.’

Damage: The normally smooth contour of the retina has large black areas where photoreceptors have been lost due to the macular degeneration

Michael plays for the England blind football team and is hoping to get picked for this year's Paralympic Games.

‘It's incredibly competitive but I'm training all the time,’ he said.

The Arsenal fans will undertake the London-Amsterdam tandem bike ride on April 6 to raise awareness of their condition.

They hope to raise over ?3,000 for Blind in Business, a charity which helps blind and partially sighted people into work.

Dan Mitchell, training and fundraising manager at Blind in Business, said: ‘Having the Smith brothers embark on such a challenging journey to raise money for this small charity shows they always want to work towards bigger challenges.

‘They have both been challenged academically and have pushed themselves as visually impaired people, working towards careers in engineering and law.’

Leber's Optic Neuropathy mostly strikes young men and is caused by complex genetic defects.

Vision loss results from the death of cells in the optic nerve responsible for relaying visual information from the eyes to the brain.

Although central vision gradually improves in a small number of cases, for most people vision loss is permanent.

Michael and Dan can be sponsored via http://www.justgiving.com/sevenmenfivebikes.

 

 

See the original post here:
Twin brothers' devastation after both rapidly lost their sight due to rare genetic condition

Education Isn’t Helping Americans Overcome Deepening Inequality

In Remaking Eden (Harper Perennial, 1998), geneticist Lee Silver envisioned a future in which humanity has split into two species: “Naturals,” the poor slobs who muddle along with the genes that nature gave them, and the “GenRich,” who can afford to boost their physical and mental talents via genetic engineering. Silver warns that over time, “the genetic distance between the Naturals and the GenRich has become greater and greater, and now there is little movement up from the Natural to GenRich class.”

We don’t have to wait until science catches up to science fiction for this unjust dystopia to be realized. It’s happening now, in the United States, as a result of policies that favor the rich at the expense of un-rich. Scholars are confirming with empirical studies what Occupy Wall Street protesters have been saying: our system is unfairly rigged in favor of the haves, who keep pulling away from have-nots.

Education can help the poor climb their way to a higher socioeconomic status. But according to Sabrina Tavernise of The New York Times, several studies have shown that “the achievement gap between rich and poor children is widening, a development that threatens to dilute education’s leveling effects.”

Race plays less of a role than it once did in this widening chasm. A study published last year by sociologist Sean Reardon found that the difference between standardized test scores of blacks and whites has narrowed since 1960, while the difference between low-income and wealthy students has surged 40 percent. “We have moved from a society in the 1950s and 1960s,” Reardon told The Times, “in which race was more consequential than family income, to one today in which family income appears to be more determinative of educational success than race.”

The simplest explanation for the divide is that the rich can afford to send their children to better schools, hire private tutors for them and give them other advantages. In 1972, affluent parents spent five times as much on their children, on average, as low-income parents; by 2007, that difference had almost doubled, to nine to one. “The pattern of privileged families today is intensive cultivation,” sociologist Frank Furstenberg told The Times.

The federal tax code is also stacked against the poor. The code caps taxes on long-term capital gains and dividends at 15 percent, which is why Mitt Romney is taxed at a lower rate than a grade-school teacher. Far from being progressive, with percentages rising with income, the tax code is regressive in this key area. Those who work for a living pay more in taxes, percentage-wise, than those who live off investments.

Political scientist Andrew Hacker documents the depths of our inequality in “We’re More Unequal Than You Think,” in The New York Review of Books this month. He estimates that since 1985 “the lower 60 percent of households have lost $4 trillion, most of which has ascended to the top 5 percent.” U.S. economic policies, Hacker says, now serve as a “giant vacuum cleaner” sucking money from low-income people and showering it upon the rich.

Economists quantify the inequality of a society on a scale called the Gini index. If everyone has the same income, the Gini index is zero; if one person makes all the moola, the Gini index is one. The U.S. Gini index has risen from .359 in 1972 to .440 in 2010, an increase of more than 20 percent, Hacker reports. In contrast, the Gini index of socialist Sweden is .230.

Hacker notes that “in a not-so-distant past, families of modest means made enough to put something aside for their children’s college fees. That cushion is gone, which is why millions of undergraduates are now forced to take much larger loans. Adding interest and penalties, many will face decades paying off six-figure debts.” (I’m facing this financial challenge myself; my son is entering college next fall and my daughter a year later.)

The U.S. exemplifies the Matthew effect, a sociological term that alludes to a passage in the Gospel of Matthew: “For to all those who have, more will be given, and they will have an abundance; but from those who have nothing, even what they have will be taken away.”

Our current presidential race features several Christian candidates—Rick Santorum, Newt Gingrich and Romney—who seem to view the Matthew effect as the Eleventh Commandment. These men trumpet their religiosity and rectitude, and yet they advocate economic policies that benefit the rich and hurt the poor, violating the most basic rules of moral decency. Naturals must join together with rich people with a conscience to create a more economically just society.

Image courtesy Wikimedia Commons, http://www.flickr.com/tracy_olson.

Link:
Education Isn't Helping Americans Overcome Deepening Inequality

DNA evidence may prove pivotal in Melanie case

DNA evidence may prove pivotal in Melanie case

Monday, February 13, 2012

Gardaí will know as early as today if they have a DNA match linking a key suspect to last week’s murder of Melanie McCarthy.

Gardaí have retrieved a "clear image" from a CCTV camera of a suspect which was recovered from where the killers of the 16-year-old dumped their jeep last Tuesday night.

Garda sources said they don’t yet know if this man was in the jeep, but have established from his record and his criminal associates that he "fits the picture" and is "well prepared" to kill.

However, it won’t be until officers get the results of DNA tests from the murder weapon and other evidential items until they can definitively link this man to the crime.

Garda sources said they hope to get the results of the tests either today or tomorrow.

If they get a positive confirmation they will then go looking for the man, apply for search warrants and seek to arrest him.

Detectives said there was no point arresting the man before they get these results.

The garda investigation team has drawn up a list of eight potential suspects who could be among the killers.

Detectives believe at least two men were in the 4x4 used in the murder, which happened in Brookfield estate, Tallaght, west Dublin.

Melanie was sitting in the back seat of a car parked on Brookview Way at around 10.35pm, when gunmen in a black Hyundai Santa Fe 4x4 pulled up alongside.

The 4x4 was driven a short distance to Citywest and abandoned at Brown’s Barn, off the Naas Road.

They failed to set fire to the vehicle to destroy forensic evidence.

They also dumped the shotgun, balaclavas, scarf and gloves near the scene.

Detectives have identified a number of suspects, including a key individual from Ballyfermot. Garda sources said that many of them are "small enough" in terms of their activities.

a d v e r t i s e m e n t

 

Follow this link:
DNA evidence may prove pivotal in Melanie case

Posted in DNA

FBI Won’t Check DNA Profile In 20-Year-Old Murder Case

Holly Staker, 11, was brutally raped and murdered in Waukegan in 1992. (Credit: CBS)

WAUKEGAN, Ill. (CBS) — The FBI is not going to be checking a DNA profile in a nearly 20-year old Chicago area murder case that reopened last month.

As WBBM Newsradio’s Bernie Tafoya reports, the murder case of Holly Staker, 11, of Waukegan, was reopened last month after a judge ordered the man convicted of killing her to be freed from prison. Juan Rivera was freed partly because of DNA evidence.

LISTEN: WBBM Newsradio’s Bernie Tafoya reports

But the Chicago Tribune reports that because the DNA profiling was conducted by a California lab that is not accredited by the federal government, the FBI will not be running the profile through its computers. The FBI system contains DNA information on more than 10 million people.

The Center for Wrongful Convictions at Northwestern University criticized the FBI’s stance. One of its attorneys , Jane Raley, told the Tribune that the DNA has provided the genetic fingerprint of Staker’s killer, and all they need is his identity.

Staker was fatally stabbed and sexually assaulted while babysitting two younger children on Aug. 17, 1992. Investigators had always thought they had the killer, Juan Rivera, who had confessed after a long interrogation, but whose DNA was not a match.

Rivera was convicted three times – in 1993, 1998 and 2009 – but his conviction was overturned each and every time.

Last month, Rivera walked out of Stateville Correctional Center in Joliet after being locked up for 19 years.

Rivera’s 2009 conviction was “unjustified and cannot stand” because of a lack of evidence tying him to Staker’s rape and murder, the 2nd District Appellate Court panel said in its 3-0 ruling in December.

Lake County prosecutors decided not to challenge the decision, and the Center on Wrongful Convictions volunteered to help find the real killer.

The rest is here:
FBI Won’t Check DNA Profile In 20-Year-Old Murder Case

Posted in DNA

Planet of the Apes: As in ‘Star Trek,’ would aliens be similar to us?

On Star Trek, the aliens often look so human that crew members fall in love with them. But in real life, scientists in the field known as astrobiology can't be sure alien life would even be carbon-based like us, or use DNA to carry a genetic code.

Some insight now is coming from earthly labs, where scientists are building alternative kinds of genetic codes, and showing how they can evolve.

Whether life could be built with an alien biochemistry was among the more interesting questions that came up during a public event with famed biologist Richard Dawkins and physicist Lawrence Krauss, author of the book The Physics of Star Trek.

Dawkins saw the question as a biological equivalent of one posed by Einstein: Did God have any choice in making the universe? Not that Einstein believed in a biblical God, as the famously atheistic Dawkins was quick to point out.

Dawkins noted that 99 percent of the living things that ever existed are now extinct. The way carbon-based life works on Earth is downright wasteful, he said. "Any decent engineer would have sent it back to the shop."

The event, which drew more than 3,000 people, was held at Arizona State University in Tempe. Dawkins didn't lecture but instead took part in an onstage discussion with Krauss, who runs a multidisciplinary program there on the origins of humanity, life, and the cosmos.

Krauss - while not going so far as to say alien chicks would be hot - did say the laws of physics and chemistry might favor carbon-based life resembling ours.

Dawkins said he was inclined to think life could exist in more diverse forms, as long as it included some kind of code-carrying system equivalent to DNA, copying itself with high fidelity. Such genetic material is critical for Darwinian evolution, which, to Dawkins and many others, is the defining characteristic of life.

Perhaps it wasn't a complete coincidence that at the same university, biochemist John Chaput was creating an alternative version of DNA, called TNA, and had last month published the first evidence that the stuff can undergo Darwinian evolution.

Chaput, who works at ASU's Biodesign Institute, said Dawkins is correct to emphasize the need for genetic material - something that can carry a code. All known life does this with DNA and RNA.

NASA has taken a great interest in such possible alternative code-carriers. In late 2010 the space agency claimed that scientists had forced a bacteria to substitute arsenic for phosphorus in its DNA. Despite the fanfare, the team never presented adquate evidence that alternative life really existed, said chemist Steve Benner of the Florida-based Foundation for Applied Molecular Evolution.

And when biochemist Rosemary Redfield of the University of British Columbia tried to replicate this, she discovered that the bacteria failed to grow when fed arsenic and no phosphorus.

Benner said the original arsenic life paper admitted to a small amount of phosphorus contamination. From the start, he said, he thought the contamination was fooling the team into thinking the organism was using arsenic the way we use phosphorus.

Benner said this new TNA work is just as exciting and relevant to astrobiology as the arsenic bacteria would have been if it had been proved.

This alternative genetic material is like RNA in that it's single-stranded and it carries a chemical code with four different units. But the backbone that holds it together has a different structure, incorporating a sugar called threose where RNA has a sugar called ribose.

Threose is found in meteorites, said Chaput, suggesting it can form spontaneously in the absence of life. It's also simpler than RNA, making it a reasonable candidate for a precursor to our current genetic material.

The existence of a precursor fits with the widely held view that life didn't start out as complex as even the simplest microbes today. Instead, the simplest known living things evolved from yet simpler life that no longer exists.

Chaput showed that, like RNA, TNA can undergo Darwinian evolution. In theory, then, life elsewhere could use TNA as its genetic code, and if early life on Earth used it, TNA-based life could evolve into DNA-based life.

To demonstrate TNA evolution, he used selection to prompt the molecules to do a fairly simple task - to stick to a specific protein. This is what so-called receptors do in our bodies. He continued to select those TNA molecules that best stuck to the protein until he had a decent receptor.

TNA evolution worked the same way as in DNA, with accidental mutations leading to variation, and natural selection amplifying those variants that are best at surviving and reproducing themselves.

That suggests the possibility of TNA-based life elsewhere, said Benner. It's also possible, he said, that arsenic-using DNA would be stable, say, under the frigid conditions of Saturn's moon Titan.

So now we have TNA and code-carrying molecules that use six or 12 characters rather than the usual four. With these increasing possibilities known, Benner sides more closely with Dawkins on the question of life forms with alternative chemistries.

Our life is not the best of all possible forms, Benner said, but a product of chance, our biochemistry hinging on which molecules happened to bump into each other. God did have alternatives, in other words, but chance determined which one would evolve to create works like Star Trek.

 

Contact staff writer Faye Flam at 215-854-4977, fflam@phillynews.com, on her blog at http://www.philly.com/evolution, or @fayeflam on Twitter.

Read the rest here:
Planet of the Apes: As in 'Star Trek,' would aliens be similar to us?

Upcoming regional science fair needs volunteer judges

    Volunteer judges are needed for the Montana Tech regional science fair Feb. 28 and March 1.

    According to a news release, high school judging (requires judges have a MS degree) takes place 9 to 11:30 a.m. on Tuesday, Feb. 28, in Tech's SUB. Categories by which students are judged are Team, Computer Science, Environmental Science, Zoology, Physics, Microbiology, Medicine and Health, Math, Engineering, Earth and Space, Chemistry, Botany, and Behavioral Science.

    Elementary judging takes place 9 a.m. to noon and junior high judging is noon to 3 p.m. on Thursday, March 1, in Tech's HPER complex. There are no educational requirements to be an elementary or junior high judge. Attempts are made to place judges in the area where they are most comfortable with choices being Earth, Life, Physical or Behavioral science.

    For details, email to Amy Verlanic at Averlanic@mtech.edu.

Read more from the original source:
Upcoming regional science fair needs volunteer judges

Plastic surgery reported up despite economy

Anti-aging procedures that don’t involve going under the knife drove the growth of cosmetic medicine in 2011, a new report from the American Society of Plastic Surgeons says.
.
The plastic surgery market saw  ”signicant” growth for the second year in a row, the group says, with cosmetic and reconstructive plastic surgery each up 5%.

“While the rate of economic recovery in the U.S. is still uncertain, 2011 proved to be a good year for plastic surgery,” ASPS President Dr. Malcolm Z. Roth said.

Some local plastic surgeons in Orange County, one of the cosmetic medicine capitals, see things somewhat differently. 

“Even though these statistics are derived from surveying our membership, I find them not totally credible,” said Dr. Edward Jonas Domanskis of Newport Beach. “In my experience, the total number of cosmetic surgery procedures, both surgical and non-surgical, has either decreased from the past year or stayed the same.”

Dr. John Di Saia of San Clemente and Orange took the report in stride.

“Things are looking up in the cosmetic surgery market but only slightly. 5% is not a major increase,” he said. “The larger procedures are still slow to return in large numbers. It is a sign of the economy.”

Another plastic surgeon said he thinks the statistics are spot on.

“The recent figures from the American Society of Plastic Surgeons on procedures performed in 2011 are consistent with the trends in my practice,” said Dr. Donald Altman of Irvine, adding, “… Despite the modest increase in procedures performed in 2011, consumers seeking cosmetic surgery continue to be very price sensitive.”

 The ASPS says 13.8 million cosmetic plastic surgery procedures — both surgical and minimally-invasive such as Botox or filler injections – were performed in the United States in 2011.

Also, 5.5 million reconstructive plastic surgery procedures were performed last year, up 5%, as well.

Cosmetic surgery went up 2%, with nearly 1.6 million procedures in 2011, the ASPS said.

The top five surgical procedures were:

Breast augmentation (307,000 procedures, up 4%) Nose reshaping (244,000 procedures, down 3%) Liposuction (205,000 procedures, up 1%) Eyelid surgery (196,000 procedures, down 6%) Facelift (119,000 procedures, up 5%)

Facelifts were listed among the top five cosmetic surgical procedures for the first time since 2004, replacing tummy tucks.

“We are seeing notable increases in surgical procedures, such as facelifts, that reflect the demands of an aging boomer population,” Roth said. ”However, the overall growth in cosmetic procedures is being primarily driven by a substantial rise in minimally-invasive procedures.”

Cosmetic minimally-invasive procedures increased 6%, with nearly 12.2 million procedures in 2011, according to the ASPS.

The top five minimally-invasive procedures were:

Botulinum toxin type A — mostly Botox (5.7 million procedures, up 5%) Soft tissue fillers (1.9 million procedures, up 7%) Chemical peel (1.1 million procedures, down 3%) Laser hair removal (1.1 million procedures, up 15%) Microdermabrasion (900,000 procedures, up 9%)

Soft tissue fillers like hyaluronic acid (such as Restylane and Juvederm Ultra), calcium hydroxylapatite (Radiesse), and fat injections had  some of the largest growth in the minimally-invasive market last year.

The ASPS said more than 1.3 million hylauronic acid procedures were performed in 2011, up 9%; 286,000 calcium hydroxylapatite procedures, up 36%; and 68,000 fat injections, up 19%.

Lip augmentation practically exploded – up 49%, with more than 25,000 procedures performed, according to the ASPS.

Procedures by gender will be released in upcoming weeks. But chin augmentation, a procedure the ASPS says is popular with men, nearly doubled in 2011, with 21,000 procedures performed, up 71%, according to the organization. 

Here’s some more from local plastic surgeons:

Dr. Terry Dubrow of Newport Beach:

“I think these numbers reflect that things have pretty much stabilized. No great increases or decreases in the demand or utilization of plastic surgery. The fact that most procedures seem to be up in single digit percentage point gains reflect in my mind nothing more than statistical variation. I have a rather established practice and I appear frequently on television and despite that some months last year were slower than I would expect if things were really improving.”

Dr. Edward Jonas Domanskis of Newport Beach:

“Definitely, the surgical cosmetic procedures continue at least in my practice and Orange County, to be significantly impacted by the economy with less expendable and spendable income. I feel that this is also because consumers confidence levels are still low.”

Dr. Donald Altman of Irvine:

“Breast augmentation continues to be the most popular cosmetic surgical procedure followed by rhinoplasty. There has been a dramatic increase in breast reconstruction this past year. Patients seem to be better informed in their decisions regarding cosmetic surgery, probably reflecting their increased ability to access information online. Email and text messaging has improved my ability to communicate with patients exponentially.”

.

See also:
.

 

 ————————————————————————————————————————————————–

.

Latest from this blog:
.

.

Go here to see the original:
Plastic surgery reported up despite economy

Stem Cell Therapy for Deafness

MANILA, Philippines - US researchers have begun a groundbreaking trial to test the potential of umbilical cord blood transplants, a kind of stem cell therapy, to treat and possibly reverse hearing loss in infants.

The Phase I trial follows promising studies on mice showing that such transplants were able to rebuild the structures of the inner ear, and some anecdotal evidence from humans, sparking hope of a cure for some forms of deafness.

One of those people is two-year-old Finn McGrath, who suffered brain damage after being deprived of oxygen during a prolonged and complicated delivery, according to his mother, Laura.

"His doctors told us he was at high risk for cerebral palsy, vision issues, hearing problems, and mental retardation," she said in an interview with AFP.

Finn's early days were an all-out struggle to survive, so for his parents, learning that he had failed his hearing tests and had damaged hair cells - the sensory receptors in the inner ear that pick up sounds - was almost an afterthought.

He had organ failure, breathing problems, and his cerebral palsy left him unable to roll, crawl, or walk, hold his head up, talk, or eat.

As his parents searched for ways to help him, they came upon stories online that told of studies using cord blood to help children with cerebral palsy and other disorders.

Prior to his birth, the McGraths had arranged to privately bank his umbilical cord blood, a procedure that costs around $2,000 plus storage fees, and remains controversial among pediatricians.

Private companies such as the Cord Blood Registry, which is funding the Texas study on hearing loss, urge expecting parents to bank their umbilical cord blood and reserve it for personal use as a way to protect their family.

That advice runs counter to the guidelines issued by the American Academy of Pediatrics in 2007, which calls such claims "unsubstantiated" and says banking for personal or family use "should be discouraged" but is "encouraged" if it is to be stored in a bank for public use.

Since Finn's parents had already banked his, they enrolled him in cord blood trial for cerebral palsy in North Carolina and he received his first transplant in November, 2009, when he was about seven weeks old.

A second transfusion followed and by May, his parents began to notice a change.

Nighttime noises, like an alarm on his food pump or the sound of ripping medical tape, would suddenly startle him awake, his mother recalled.

"He started vocalizing sounds and we could tell that he was anticipating things that we would say. Like, if he had heard a story a number of times or a song, he would smile like he recognized the song or the story."

Finn had a third infusion in September, 2010, when he was one year old. Four months later, an otoacoustic emissions test (OAE), which plays a sound and picks up vibrations in the cochlea and hair cells, came back normal.

The early hearing tests that showed hearing loss were not exactly the same as the later tests that came back normal, so McGrath is cautious about comparing them directly, but she believes the cord blood transfusions may have helped.

"All I can tell you is anecdotally he was not able to hear for probably the first three or four months of his life, and then when he was about six to eight months old, he started hearing."

The hearing trial in Texas aims to take a first step in testing the safety, and later the efficacy, of transfusing cord blood in children age six weeks to 18 months who have sustained post-birthsensorineural hearing loss.

Some reasons that children lose their hearing at or after birth may include oxygen deprivation, head injury, infection, strong doses of antibiotics, or loud noises.

Sensorineural hearing loss affects approximately six per 1,000 children, and there is no available medical treatment. Hearing aids or cochlear implants are typically offered to boost the ability of the damaged tissues.

"Stem cell therapy may potentially repair the damaged structures of the inner ear and restore normal hearing," lead investigator Samer Fakhri told AFP.

"We are at the initial stages of this process and the results are looking promising," Fakhri added.

Read the original:
Stem Cell Therapy for Deafness